These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 2446137

  • 21. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
    Yue Q, Hu X, Yin W, Xu X, Wei S, Lei Y, Lü X, Yang J, Su M, Xu Z, Hao X.
    J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
    [Abstract] [Full Text] [Related]

  • 22. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos.
    Zamorano P, Wigdorovitz A, Chaher MT, Fernandez FM, Carrillo C, Marcovecchio FE, Sadir AM, Borca MV.
    Virology; 1994 Jun; 201(2):383-7. PubMed ID: 8184548
    [Abstract] [Full Text] [Related]

  • 23. Localization of infection-related epitopes on the non-structural protein 3ABC of foot-and-mouth disease virus and the application of tandem epitopes.
    Sun T, Lu P, Wang X.
    J Virol Methods; 2004 Aug; 119(2):79-86. PubMed ID: 15158588
    [Abstract] [Full Text] [Related]

  • 24. The core antigen of hepatitis B virus as a carrier for immunogenic peptides.
    Murray K, Shiau AL.
    Biol Chem; 1999 Mar; 380(3):277-83. PubMed ID: 10223329
    [Abstract] [Full Text] [Related]

  • 25. [Synthetic peptides simulating the protective epitopes of VP1 protein of foot-and-mouth disease virus type O and A].
    Surovoĭ AIu, Vol'pina OM, Ivanov VT, Chepurkin AV, Ivaniushchenkov VN.
    Bioorg Khim; 1987 Aug; 13(8):1132-5. PubMed ID: 2445357
    [Abstract] [Full Text] [Related]

  • 26. Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-Kaufbeuren.
    Liebermann H, Holl U, Reimann I, Nöckler A, Schäfer D, Thalmann G, Dölling R.
    Arch Exp Veterinarmed; 1990 Aug; 44(6):883-90. PubMed ID: 1966360
    [Abstract] [Full Text] [Related]

  • 27. Stability governs the apparent expression of "particulate" hepatitis B e antigen by mutant hepatitis B virus core particles.
    Seifer M, Standring DN.
    Virology; 1993 Sep; 196(1):70-8. PubMed ID: 7689282
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y, Xiong X, Liu X, Li J, Wen Y, Chen Y, Dai Q, Cao Z, Yu W.
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [Abstract] [Full Text] [Related]

  • 30. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
    Shiau AL, Murray K.
    J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
    Gedvilaite A, Frömmel C, Sasnauskas K, Micheel B, Ozel M, Behrsing O, Staniulis J, Jandrig B, Scherneck S, Ulrich R.
    Virology; 2000 Jul 20; 273(1):21-35. PubMed ID: 10891404
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Antigenic structure of the foot-and-mouth-disease virus. I. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth virus type O1K].
    Surovoĭ AIu, Vol'pina OM, Snetkova EV, Volkova TD, Ivanov VT.
    Bioorg Khim; 1988 Oct 20; 14(10):1352-62. PubMed ID: 2852937
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Construction and characterization of hepatitis B surface antigen "a" epitope virus-like particles].
    Chen SY, Guo MZ, Qiu F, Fei YL, Yi Y, Guo Y, Jia ZY, Yu T, Bi SL.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb 20; 24(1):30-2. PubMed ID: 20848844
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Analysis of the antigenicity of the expression product of fusion antigen epitope genes of FMDV].
    Wang DM, Shen WT, Li XY, Zhou P.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Nov 20; 24(11):1048-50. PubMed ID: 18992188
    [Abstract] [Full Text] [Related]

  • 39. Recombinant heat shock protein 65 carrying hepatitis B core antigen induces HBcAg-specific CTL response.
    Yang BF, Zhao HL, Xue C, Xiong XH, Zhang W, Yao XQ, Liu ZM.
    Vaccine; 2007 May 30; 25(22):4478-86. PubMed ID: 17467856
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.